Bioorganic & Medicinal Chemistry Letters 2010-06-01

Prenylcoumarin with Rev-export inhibitory activity from Cnidii Monnieris Fructus.

Satoru Tamura, Toshiaki Fujitani, Masafumi Kaneko, Nobutoshi Murakami

Index: Bioorg. Med. Chem. Lett. 20 , 3717-20, (2010)

Full Text: HTML

Abstract

By use of the fission yeast expressing the model fusion protein comprised of GST, SV40 T antigen NLS, GFP, and Rev-NES in the bioassay, the prenylcoumarin osthol (1) was disclosed as the new Rev-export inhibitor from the MeOH extract of Cnidii Monnieris Fructus. Furthermore, 1 was also found to inhibit export the genuine Rev in HeLa cells by indirect fluorescent antibody technique. By the competitive experiment using the biotinylated probe 3, osthol (1) was revealed to inhibit nuclear export of Rev through a NES non-antagonistic mode. Structure-activity relationship analysis of several analogs of 1 clarified that both prenyl side chain and double bond adjacent to the lactone carbonyl residue play an important role in the Rev-export inhibitory potency of 1.


Related Compounds

  • Coumarin
  • 7-Methoxycoumarin

Related Articles:

Proteasome functioning in breast cancer: connection with clinical-pathological factors.

2014-01-01

[PLoS ONE 9(10) , e109933, (2014)]

Mitochondrial targeting of bilirubin regulatory enzymes: An adaptive response to oxidative stress.

2015-01-01

[Toxicol. Appl. Pharmacol. 282(1) , 77-89, (2015)]

Pre-clinical evaluation of AZD-2014, a novel mTORC1/2 dual inhibitor, against renal cell carcinoma.

2015-02-28

[Cancer Lett. 357(2) , 468-75, (2015)]

In vitro assessment of the multifunctional bioactive potential of Alaska pollock skin collagen following simulated gastrointestinal digestion.

2015-05-01

[J. Sci. Food Agric. 95(7) , 1514-20, (2015)]

The Japanese toxicogenomics project: application of toxicogenomics.

2010-02-01

[Mol. Nutr. Food. Res. 54 , 218-27, (2010)]

More Articles...